Skip to main content
KALV logo
KALV
(NASDAQ)
KalVista Pharmaceuticals, Inc.
$19.90-- (--)
Loading... - Market loading

KalVista Pharmaceuticals (KALV) Stock Price & Financial Analysis

KalVista Pharmaceuticals Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$19.26 - $20.11
52-Week High$21.31
52-Week Low$9.24
Open$19.55
Volume910.20K
Average Volume (3M)910.20K
Market Cap1.07B
Shares Outstanding53.88M
Price to Sales (P/S)70.46
Price to Book (P/B)62.67
EV/EBITDA-5.12
Revenue (TTM)15.12M
Net Income (TTM)-210.31M
Free Cash Flow (TTM)-161.33M
EPS (TTM)$-3.90
Profit Margin-1391.14%
Operating Margin-1309.80%
Return on Equity (ROE)-1237.21%
Debt to Equity8.26
50-Day MA$16.31
200-Day MA$14.27
52-Week Change77.23%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About KalVista Pharmaceuticals

What is the current stock price for KALV?

As of the latest trading session, KALV stock trades at $19.90. The 52-week range is $9.24–$21.31, with a day range of $19.26–$20.11.

What is the P/E ratio for KALV?

The P/E ratio (Price-to-Earnings) for KALV is shown in the Key Statistics section. This valuation metric helps compare KalVista Pharmaceuticals, Inc. to industry peers.

Does KALV pay dividends?

KalVista Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for KALV?

Based on 4 analysts, the consensus for KALV is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of KALV?

KalVista Pharmaceuticals's market capitalization is $1.07B, classifying it as a small-cap company. KalVista Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.